Skip to content
The Mumbai

Aurobindo Pharma Receives USFDA Final Approval For Perampanel Tablets, Market Size Estimated At ₹558 Crore

Aurobindo Pharma Receives USFDA Final Approval For Perampanel Tablets, Market Size Estimated At ₹558 Crore
Photo: Free Press Journal · view original

Mumbai: Aurobindo Pharma announced on October 3, 2026, that it has received final approval from the USFDA to manufacture and market Perampanel Tablets in 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg strengths. These tablets are bioequivalent and therapeutically equivalent to Fycompa® Tablets from Cat...

Sources and story details